Cargando…
Correction: EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment
Autores principales: | Zhang, Hongjuan, Zhan, Cheng, Ke, Ji, Xue, Zhiqiang, Zhang, Aiqun, Xu, Kaifeng, Shen, Zhirong, Yu, Lei, Chen, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6219665/ https://www.ncbi.nlm.nih.gov/pubmed/30443297 http://dx.doi.org/10.18632/oncotarget.26255 |
Ejemplares similares
-
EGFR kinase domain mutation positive lung cancers are sensitive to intrapleural perfusion with hyperthermic chemotherapy (IPHC) complete treatment
por: Zhang, Hongjuan, et al.
Publicado: (2015) -
Hyperthermic intrapleural chemotherapy: an update
por: Campany, Megan E., et al.
Publicado: (2023) -
Abrupt hemodynamic changes accompanying intrapleural hyperthermic chemotherapy: Case series
por: Kim, Hyae-Jin, et al.
Publicado: (2018) -
Cytoreductive surgery combined with hyperthermic intrapleural chemotherapy to treat thymoma or thymic carcinoma with pleural dissemination
por: Yu, Lei, et al.
Publicado: (2013) -
Better effect of intrapleural perfusion with hyperthermic chemotherapy by video‐assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity
por: Cao, Yejun, et al.
Publicado: (2021)